A prospective, randomized, controlled clinical trial on the efficacy of a single-use negative pressure wound therapy system, compared to traditional negative pressure wound therapy in the treatment of chronic ulcers of the lower extremities.


Journal

Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society
ISSN: 1524-475X
Titre abrégé: Wound Repair Regen
Pays: United States
ID NLM: 9310939

Informations de publication

Date de publication:
09 2019
Historique:
received: 12 07 2018
revised: 24 04 2019
accepted: 09 05 2019
pubmed: 16 5 2019
medline: 7 7 2020
entrez: 16 5 2019
Statut: ppublish

Résumé

Multicenter, phase-4, randomized, comparative-efficacy study in patients with VLUs or DFUs comparing for noninferiority the percentage change in target ulcer dimensions (area, depth, and volume) a single-use negative pressure wound therapy (s-NPWT) system versus traditional NPWT (t-NPWT) over a 12-week treatment period or up to confirmed healing. Baseline values were taken at the randomization visit. Randomized by wound type and size, 164 patients with non-infected DFUs and VLUs were included. The ITT population was composed of 161 patients (101 with VLUs, 60 with DFUs) and 115 patients completed follow-up (64 in the s-NPWT group and 51 in the t-NPWT group) (PP population). The average age for all patients was 61.5 years, 36.6% were women, and treatment groups were statistically similar at baseline. Primary endpoint analyses on wound area reduction demonstrated statistically significant reduction in favor of s-NPWT (p = 0.003) for the PP population and for the ITT population (p < 0.001). Changes in wound depth (p = 0.018) and volume (p = 0.013) were also better with s-NPWT. Faster wound closure was observed with s-NPWT (Cox Proportional Hazards ratio (0.493 (0.273, 0.891); p = 0.019) in the ITT population. Wound closure occurred in 45% of patients in the s-NPWT group vs. 22.2% of patients in the t-NPWT group (p = 0.002). Median estimate of the time to wound closure was 77 days for s-NPWT. No estimate could be provided for t-NPWT due to the low number of patients achieving wound closure. Device-related AEs were more frequent in the t-NPWT group (41 AEs from 29 patients) than in the s-NPWT group (16 AEs from 12 patients). The s-NPWT system met noninferiority and achieved statistical superiority vs. t-NPWT in terms of wound progression toward healing over the treatment period. When NPWT is being considered for the management of challenging VLUs and DFUs, s-NPWT should be considered a first choice over other types of NPWT.

Identifiants

pubmed: 31087729
doi: 10.1111/wrr.12727
pmc: PMC6852528
doi:

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

519-529

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2019 The Authors. Wound Repair and Regeneration published by Wiley Periodicals, Inc. on behalf of by the Wound Healing Society.

Références

Diabetes Metab Res Rev. 2016 Jan;32 Suppl 1:169-78
pubmed: 26451519
J Vasc Surg. 2006 Nov;44(5):1029-37; discussion 1038
pubmed: 17000077
J Wound Care. 2015 Sep;24 Suppl 9:S4-S12
pubmed: 26352284
Am J Surg. 2011 Apr;201(4):544-56
pubmed: 21421104
Br Med J (Clin Res Ed). 1987 May 30;294(6584):1389-91
pubmed: 3109669
Int Wound J. 2015 Apr;12(2):195-201
pubmed: 23647737
Ostomy Wound Manage. 2014 Mar;60(3):30-6
pubmed: 24610558
J Vasc Surg. 2016 Feb;63(2 Suppl):3S-21S
pubmed: 26804367
Diabetes Care. 2008 Apr;31(4):631-6
pubmed: 18162494
J Plast Reconstr Aesthet Surg. 2011 Sep;64 Suppl:S1-16
pubmed: 21868296
Burns. 2012 Jun;38(4):573-7
pubmed: 22100423
Lancet. 2005 Nov 12;366(9498):1704-10
pubmed: 16291063
World J Orthop. 2015 May 18;6(4):387-93
pubmed: 25992316
Biomed Res Int. 2014;2014:297230
pubmed: 24696847
J Wound Care. 2011 Jan;20(1):35-7
pubmed: 21278639
Vasc Med. 2015 Apr;20(2):168-81
pubmed: 25832604
J Clin Invest. 2007 May;117(5):1219-22
pubmed: 17476353
J Wound Ostomy Continence Nurs. 2014 May-Jun;41(3):233-7
pubmed: 24805174
Bone Joint Res. 2016 Aug;5(8):328-37
pubmed: 27496913
Ann Plast Surg. 1997 Jun;38(6):553-62
pubmed: 9188970
Ostomy Wound Manage. 2018 Jan;64(1):26-33
pubmed: 29406300
J Tissue Viability. 2011 Dec;20 Suppl 1:S1-18
pubmed: 22119531
Wound Repair Regen. 2012 May-Jun;20(3):332-41
pubmed: 22564228
Curr Opin Infect Dis. 2015 Apr;28(2):151-7
pubmed: 25692273
Wounds. 2015 Jul;27(7):180-90
pubmed: 26192736
Br J Community Nurs. 2015 Jun;Suppl Community Wound Care:S14, S16-20
pubmed: 26052990
J Coll Physicians Surg Pak. 2015 Nov;25(11):789-93
pubmed: 26577962
Ann Plast Surg. 1997 Jun;38(6):563-76; discussion 577
pubmed: 9188971
J Wound Care. 2015 Feb;24 Suppl 2:S4-9
pubmed: 25647506
N Engl J Med. 2017 Oct 19;377(16):1559-1567
pubmed: 29045216
Ann N Y Acad Sci. 2018 Jan;1411(1):153-165
pubmed: 29377202
Healthcare (Basel). 2014 Sep 30;2(4):417-28
pubmed: 27429285
Cochrane Database Syst Rev. 2015 Jul 14;(7):CD011354
pubmed: 26171910
Prosthet Orthot Int. 2015 Feb;39(1):29-39
pubmed: 25614499
Plast Reconstr Surg Glob Open. 2018 Jan 12;6(1):e1560
pubmed: 29464150
Int J Clin Exp Med. 2015 Aug 15;8(8):12548-56
pubmed: 26550165

Auteurs

Robert Kirsner (R)

Chairman and Harvey Blank Professor, Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida.

Cyaandi Dove (C)

Advanced Foot & Ankle Center, Las Vegas, NV.

Alex Reyzelman (A)

Associate Professor, Department of Medicine, California School of Podiatric Medicine at Samuel Merritt University, Co-Director UCSF Center for Limb Preservation, San Francisco, CA.

Dean Vayser (D)

Scripps Clinic Medical Group, Department of Orthopedics/Foot & Ankle Center, Chief, Wound Care Division, San Diego, CA.

Henry Jaimes (H)

Global Senior Medical Director-Wounds Smith and Nephew, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH